United States Biotechnology & Medical Research

Agios Pharmaceuticals Inc (AGIO)

Track

Over the past 90 days, Agios Pharmaceuticals Inc. insiders have engaged in selling activity totaling approximately $301,006. These transactions, primarily executed by key executives including the Chief Medical Officer, were conducted as planned sales. No insider buying activity was recorded during this period, which follows a 48.8% increase in the company's stock price.
Ticker: AGIO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Agios Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 1 Jul 2026
Value US$3,076,624.96 | Price 486.62 | Shares 5,112 (+44.7%)
Proposed sale 1 Jul 2026
Value US$2,071,385.86 | Price 425.83 | Shares 64,794
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
5,112 +44.7%
486.62
US$3,076,625 		5,112 +44.7% 486.62 US$3,076,625
2026-07-01 2026-07-01 PrS Proposed sale
Gheuens Sarah

Officer

Officer
64,794
425.83
US$2,071,386 		64,794 425.83 US$2,071,386
2026-04-06 2026-04-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
7,223 -46.1%
188.57
US$235,621 		7,223 -46.1% 188.57 US$235,621
2026-04-06 2026-04-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
3,141 -5.4%
34.71
US$109,024 		3,141 -5.4% 34.71 US$109,024
2026-04-06 2026-04-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
3,280 -6.2%
34.71
US$113,849 		3,280 -6.2% 34.71 US$113,849
2026-04-06 2026-04-02 PlS Planned sale
Viswanadhan Krishnan

Chief Corp Dev & Strategy

Officer
2,959 -22.3%
34.71
US$102,707 		2,959 -22.3% 34.71 US$102,707
2026-04-06 2026-04-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
6,596 -3.5%
34.71
US$228,947 		6,596 -3.5% 34.71 US$228,947
2026-04-06 2026-04-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
12,472 -6.6%
34.71
US$432,903 		12,472 -6.6% 34.71 US$432,903
2026-04-06 2026-04-02 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
3,262 -6.5%
34.71
US$113,224 		3,262 -6.5% 34.71 US$113,224
2026-04-02 2026-04-02 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
19,068
34.19
US$651,935 		19,068 34.19 US$651,935
2026-04-02 2026-04-02 PrS Proposed sale
Gheuens Sarah

Officer

Officer
2,940
34.19
US$100,519 		2,940 34.19 US$100,519
2026-04-02 2026-04-02 PrS Proposed sale
Jones Cecilia

Officer

Officer
3,141
34.19
US$107,391 		3,141 34.19 US$107,391
2026-04-02 2026-04-02 PrS Proposed sale
Milanova Tsveta

Officer

Officer
3,262
34.19
US$111,528 		3,262 34.19 US$111,528
2026-04-02 2026-04-02 PrS Proposed sale
2.9
Burns James William

Officer

Officer
3,280
34.19
US$112,143 		3,280 34.19 US$112,143
2026-04-02 2026-04-02 PrS Proposed sale
Viswanadhan Krishnan

Officer

Officer
2,959
34.19
US$101,168 		2,959 34.19 US$101,168
2026-03-09 2026-03-05 PlS Planned sale
Viswanadhan Krishnan

Chief Corp Dev & Strategy

Officer
2,959 -36.5%
27.80
US$82,260 		2,959 -36.5% 27.80 US$82,260
2026-03-05 2026-03-05 PrS Proposed sale
Viswanadhan Krishnan

Officer

Officer
2,959
29.00
US$85,811 		2,959 29.00 US$85,811
2026-03-05 2026-03-03 S Sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
5,272 -85.9%
28.88
US$152,255 		5,272 -85.9% 28.88 US$152,255
2026-03-03 2026-03-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
5,918 -3.5%
28.96
US$171,385 		5,918 -3.5% 28.96 US$171,385
2026-03-03 2026-03-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
8,267 -5.0%
28.96
US$239,412 		8,267 -5.0% 28.96 US$239,412
2026-03-03 2026-03-02 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
3,870 -2.6%
28.96
US$112,075 		3,870 -2.6% 28.96 US$112,075
2026-03-03 2026-03-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
1,187 -1.6%
28.96
US$34,376 		1,187 -1.6% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
1,681 -2.3%
28.96
US$48,682 		1,681 -2.3% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
1,187 -1.7%
28.96
US$34,376 		1,187 -1.7% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,163 -2.6%
28.96
US$33,680 		1,163 -2.6% 28.96 US$33,680
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,187 -2.8%
28.96
US$34,376 		1,187 -2.8% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,681 -4.2%
28.96
US$48,682 		1,681 -4.2% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
1,187 -3.3%
28.96
US$34,376 		1,187 -3.3% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
1,187 -2.8%
28.96
US$34,376 		1,187 -2.8% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
1,681 -4.2%
28.96
US$48,682 		1,681 -4.2% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
798 -11.5%
28.96
US$23,110 		798 -11.5% 28.96 US$23,110
2026-03-03 2026-03-02 PlS Planned sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
727 -14.6%
28.96
US$21,054 		727 -14.6% 28.96 US$21,054
2026-03-03 2026-03-02 PlS Planned sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
698 -21.2%
28.96
US$20,214 		698 -21.2% 28.96 US$20,214
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
1,573 -3.1%
28.96
US$45,554 		1,573 -3.1% 28.96 US$45,554
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
1,187 -2.5%
28.96
US$34,376 		1,187 -2.5% 28.96 US$34,376
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
1,681 -3.8%
28.96
US$48,682 		1,681 -3.8% 28.96 US$48,682
2026-03-03 2026-03-02 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
594 -1.5%
28.96
US$17,202 		594 -1.5% 28.96 US$17,202
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Burns James William

Officer

Officer
5,218
30.23
US$157,740 		5,218 30.23 US$157,740
2026-03-02 2026-03-02 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
18,055
30.23
US$545,803 		18,055 30.23 US$545,803
2026-03-02 2026-03-02 PrS Proposed sale
Milanova Tsveta

Officer

Officer
2,868
30.23
US$86,700 		2,868 30.23 US$86,700
2026-03-02 2026-03-02 PrS Proposed sale
Gheuens Sarah

Officer

Officer
4,055
30.23
US$122,583 		4,055 30.23 US$122,583
2026-03-02 2026-03-02 PrS Proposed sale
Jones Cecilia

Officer

Officer
5,035
30.23
US$152,208 		5,035 30.23 US$152,208
2026-01-07 2026-01-05 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
2,872 -7.6%
27.02
US$77,601 		2,872 -7.6% 27.02 US$77,601
2026-01-05 2026-01-05 PrS Proposed sale
Milanova Tsveta

Officer

Officer
2,872
27.22
US$78,176 		2,872 27.22 US$78,176
2026-01-02 2025-12-30 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
6,230 -4.2%
27.09
US$168,771 		6,230 -4.2% 27.09 US$168,771
2026-01-02 2025-12-30 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
12,473 -8.4%
27.09
US$337,894 		12,473 -8.4% 27.09 US$337,894
2026-01-02 2025-12-30 PlS Planned sale
2.9
Burns James William

Chief Legal Officer

Officer
2,932 -8.5%
27.09
US$79,428 		2,932 -8.5% 27.09 US$79,428
2026-01-02 2025-12-30 PlS Planned sale
Milanova Tsveta

Chief Commercial Officer

Officer
2,932 -9.1%
27.09
US$79,428 		2,932 -9.1% 27.09 US$79,428
2026-01-02 2025-12-30 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
2,932 -7.3%
27.09
US$79,428 		2,932 -7.3% 27.09 US$79,428
2026-01-02 2025-12-30 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
2,932 -4.3%
27.09
US$79,428 		2,932 -4.3% 27.09 US$79,428
2025-12-30 2025-12-30 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
18,703
27.16
US$507,973 		18,703 27.16 US$507,973
2025-12-30 2025-12-30 PrS Proposed sale
Gheuens Sarah

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-12-30 2025-12-30 PrS Proposed sale
Jones Cecilia

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-12-30 2025-12-30 PrS Proposed sale
Milanova Tsveta

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-12-30 2025-12-30 PrS Proposed sale
2.9
Burns James William

Officer

Officer
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-11-14 2025-11-12 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
43.84
US$8,768 		200 -1.1% 43.84 US$8,768
2025-11-13 2025-11-11 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
2,454 -3.8%
43.78
US$107,436 		2,454 -3.8% 43.78 US$107,436
2025-11-12 2025-11-11 PrS Proposed sale
SARAH GHEUENS

Officer

Officer
2,454
43.78
US$107,441 		2,454 43.78 US$107,441
2025-11-03 2025-10-30 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
200 -0.3%
43.81
US$8,762 		200 -0.3% 43.81 US$8,762
2025-10-30 2025-10-30 PrS Proposed sale
SARAH GHEUENS

Officer

Officer
200
43.81
US$8,762 		200 43.81 US$8,762
2025-10-29 2025-10-27 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
3,302 -5.1%
43.92
US$145,024 		3,302 -5.1% 43.92 US$145,024
2025-10-27 2025-10-27 PrS Proposed sale
SARAH GHEUENS

Officer

Officer
3,302
43.92
US$145,028 		3,302 43.92 US$145,028
2025-10-10 2025-10-08 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
41.00
US$8,200 		200 -1.1% 41.00 US$8,200
2025-10-08 2025-10-08 PrS Proposed sale
DAVID SCADDEN

Director

Non-Executive Director
200
41.00
US$8,200 		200 41.00 US$8,200
2025-10-02 2025-09-30 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
40.00
US$8,000 		200 -1.1% 40.00 US$8,000
2025-09-30 2025-09-26 PlS Planned sale
Jones Cecilia

Chief Financial Officer

Officer
3,651 -9.7%
36.77
US$134,247 		3,651 -9.7% 36.77 US$134,247
2025-09-26 2025-09-26 PrS Proposed sale
Jones Cecilia

Officer

Officer
3,651
36.77
US$134,247 		3,651 36.77 US$134,247
2025-09-09 2025-09-05 S Sale
3.0
Washburn Theodore James Jr.

Principal Accounting Officer

Officer
8,546 -90.8%
36.87
US$315,091 		8,546 -90.8% 36.87 US$315,091
2025-08-29 2025-08-27 PlS Planned sale
Scadden David
Non-Executive Director
200 -1.1%
40.00
US$8,000 		200 -1.1% 40.00 US$8,000
2025-08-27 2025-08-27 PrS Proposed sale
DAVID T. SCADDEN

Director

Non-Executive Director
200
40.00
US$8,000 		200 40.00 US$8,000
2025-08-12 2025-08-08 PlS Planned sale
2.3
Goff Brian

Chief Executive Officer

Executive Director
11,085 -8.2%
36.67
US$406,487 		11,085 -8.2% 36.67 US$406,487
2025-08-08 2025-08-08 PrS Proposed sale
2.3
Goff Brian

Officer; Director

Executive Director
11,085
37.06
US$410,810 		11,085 37.06 US$410,810
2025-07-15 2025-07-10 PlS Planned sale
Scadden David
Non-Executive Director
1,400 -7.4%
40.00
US$56,000 		1,400 -7.4% 40.00 US$56,000
2025-07-10 2025-07-10 PrS Proposed sale
DAVID SCADDEN

Director

Non-Executive Director
1,400
40.00
US$56,000 		1,400 40.00 US$56,000
2025-07-11 2025-07-09 PlS Planned sale
Gheuens Sarah

Chief Medical Officer

Officer
847 -1.4%
38.76
US$32,830 		847 -1.4% 38.76 US$32,830
Explore more

More insider trading research around Agios Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America